GUADAGNI, FIORELLA
 Distribuzione geografica
Continente #
NA - Nord America 6.321
AS - Asia 4.546
EU - Europa 667
Continente sconosciuto - Info sul continente non disponibili 179
SA - Sud America 172
AF - Africa 59
OC - Oceania 14
Totale 11.958
Nazione #
US - Stati Uniti d'America 5.314
TR - Turchia 2.395
CN - Cina 1.065
CA - Canada 984
SG - Singapore 886
IT - Italia 257
EU - Europa 177
BR - Brasile 152
IE - Irlanda 98
IN - India 68
DE - Germania 67
FI - Finlandia 35
GB - Regno Unito 35
RU - Federazione Russa 30
SC - Seychelles 29
HK - Hong Kong 24
FR - Francia 22
ZA - Sudafrica 19
MX - Messico 18
NL - Olanda 17
BD - Bangladesh 16
RO - Romania 16
ES - Italia 15
VN - Vietnam 15
UA - Ucraina 14
ID - Indonesia 13
AU - Australia 12
SE - Svezia 11
PL - Polonia 10
IQ - Iraq 9
JP - Giappone 9
SA - Arabia Saudita 8
LT - Lituania 7
CL - Cile 6
PK - Pakistan 6
DK - Danimarca 5
GR - Grecia 4
KE - Kenya 4
PH - Filippine 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
KR - Corea 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BE - Belgio 2
CH - Svizzera 2
CR - Costa Rica 2
HU - Ungheria 2
JO - Giordania 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
AL - Albania 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
DZ - Algeria 1
EG - Egitto 1
GH - Ghana 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MN - Mongolia 1
MT - Malta 1
NE - Niger 1
NP - Nepal 1
OM - Oman 1
SI - Slovenia 1
TN - Tunisia 1
Totale 11.958
Città #
Kocaeli 2.103
San Mateo 1.619
Toronto 958
Wilmington 464
Houston 424
Santa Clara 350
Lawrence 322
Princeton 322
Beijing 287
Singapore 262
Chandler 210
Ashburn 143
Fairfield 129
Seattle 127
Woodbridge 101
Shanghai 99
Los Angeles 71
Guangzhou 66
Cambridge 55
Rome 44
Dublin 35
Shenzhen 32
Helsinki 31
Redwood City 31
The Dalles 26
Brooklyn 22
Hong Kong 19
Saint Petersburg 17
Dallas 16
Wuhan 16
Quanzhou 15
Redmond 15
Milan 14
São Paulo 14
Jiaxing 13
Johannesburg 13
Munich 12
New York 12
Rui'an 12
Xi'an 12
Nanjing 11
Wuxi 11
Pune 10
Columbus 9
Council Bluffs 9
Kyiv 9
Mexico City 9
Pesaro 9
Bandung 8
Bari 8
Dongyang 8
Jinhua 8
Taizhou 8
Warsaw 8
Chicago 7
Nantong 7
Philadelphia 7
Vicenza 7
Xuzhou 7
Zhengzhou 7
Changsha 6
Hanoi 6
Hefei 6
London 6
Phoenix 6
Rockville 6
Washington 6
Ankara 5
Belo Horizonte 5
Jinan 5
Qingdao 5
Tokyo 5
Aarhus 4
Amsterdam 4
Atlanta 4
Boston 4
Brescia 4
Chennai 4
Dhaka 4
Hangzhou 4
Hyderabad 4
Montreal 4
Mumbai 4
Nairobi 4
Riyadh 4
San Francisco 4
Shijiazhuang 4
Stockholm 4
West Jordan 4
Zibo 4
Austin 3
Berlin 3
Boardman 3
Borgosesia 3
Charlotte 3
Darwin 3
Dubai 3
Fiesole 3
Foshan 3
Frankfurt am Main 3
Totale 8.869
Nome #
Ketogenic Diet and Other Dietary Intervention Strategies in the Treatment of Cancer 110
RISK: A Random Optimization Interactive System Based on Kernel Learning for Predicting Breast Cancer Disease Progression 103
A Biospecimen Proficiency Testing Program for Biobank Accreditation: Four Years of Experience 77
TAG-72 (CA 72-4 ASSAY) AS A COMPLEMENTARY SERUM TUMOR-ANTIGEN TO CARCINOEMBRYONIC ANTIGEN IN MONITORING PATIENTS WITH COLORECTAL-CANCER 74
Genetics of ischemic stroke, stroke-related risk factors, stroke precursors and treatments 74
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms study 73
Angiogenesis and Hypertension: The Dual Role of Anti-Hypertensive and Anti-Angiogenic Therapies 66
CARCINOEMBRYONIC ANTIGEN REGULATION IN HUMAN COLORECTAL TUMOR-CELLS BY A SITE-SELECTIVE CYCLIC-AMP ANALOG - A COMPARISON WITH INTERFERON-GAMMA 66
BIOLOGIC EVALUATION OF TUMOR-ASSOCIATED GLYCOPROTEIN-72 AND CARCINOEMBRYONIC ANTIGEN EXPRESSION IN COLORECTAL-CANCER .1 61
Association between migraine and ACE gene (insertion/deletion) polymorphism: the BioBIM study 60
A Novel K-ras Mutation in Colorectal Cancer. A Case Report and Literature Review 59
Inherited coagulation disorders in cirrhotic patients with and without portal vein trhombosis (PVT) 55
Correlation between soluble CD40 ligand, VEGF plasma levels and haemostatic activation in non-small cell lung cancer (NSCLC) 54
Recombinant interferon enhances monoclonal antibody-targeting of carcinoma lesions in vivo 54
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: A prospective longitudinal study 54
Activation of blood coagulation in breast cancer - relationship to clinical outcome 54
In vitro interactions between blood platelets and human colorectal tumor cells 53
Association between carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content of colorectal cancer 53
Effect of 5-fluorouracil on carcinoembryonic antigen expression and shedding at clonal level in colon cancer cells 52
Ideal Body Mass Index (BMI) is significantly different between curatively resected and metastatic colorectal cancer (CRC) patients on chemotherapy 52
“Personal and sensitive data in the e-health-IoT universe” 52
Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: Longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers 51
Role of interleukin-6 in the diagnosis of acute aortic dissection 51
Trombofilia ereditaria e poliabortività: studio osservazionale in 150 pazienti 51
MUTATIONAL ANALYSIS IN INHERITED BREAST/OVARIAN CANCER PATIENTS FROM CENTRAL ITALY REGINA ELENA CANCER INSTITUTE OF ROME, ITALY 51
A METASTATIC NUDE-MOUSE MODEL OF HUMAN PANCREATIC-CANCER CONSTRUCTED ORTHOTOPICALLY WITH HISTOLOGICALLY INTACT PATIENT SPECIMENS 51
Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey 51
Intraoperative radioimmunolocalization of an anti-CEA MAb F(Ab')(2) (F023C5) in CEA serum-negative colorectal cancer patients 50
TARGETING ANTIBODIES TO LIVE TUMOR-TISSUE IN 3-D HISTOCULTURE 50
CORRELATION BETWEEN POSITIVE CA-72-4 SERUM LEVELS AND LYMPH-NODE INVOLVEMENT IN PATIENTS WITH GASTRIC-CARCINOMA 50
Association of low-grade inflammation and platelet activation in patients with hypertension with microalbuminuria 50
PD-L1 Is Highly Expressed in Malignant Mesothelioma and PD-1(+)Lymphocytes within Malignant Effusions Induce PD-L1 Expression 49
SERUM LEPTIN LEVELS IN COLORECTAL CANCER PATIENTS 49
Soluble CD40 ligand (sCD40L) plasma levels in non-small cell lung cancer 49
A NOVEL NONSENSE MUTATION IN KRAS GENE 49
Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients 49
Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: Lack of correlation 48
Sentinel lymphadenectomy in cutaneous melanoma 48
High-sensitive D-dimer Determination for the Prediction of Chemotherapy-associated Venous Thromboembolism in Lung Cancer Patients 48
Soluble E-selectin levels and CEA expressing blood-borne cells in colorectal cancer patients. A causal relationship? 48
The pharmacokinetic profile of levodopa administered with and without tolcapone in patients with advanced PD 48
A reliable and reproducible technique for DNA Fingerprinting in Biorepositories: A Pilot Study from BioBIM 48
PAI-1 4G/5G repeat is a target in gastric carcinomas with microsatellite instability 48
Metabolic Syndrome (MetS) in Metastatic (m) Colorectal Cancer (CRC) Patients (pts) Might Delay the Onset of Cachexia 47
BIOLOGIC AND CLINICAL CORRELATIONS AMONG PLOIDY, CELL-KINETICS, AND THE TUMOR-ASSOCIATED GLYCOPROTEIN-72 TISSUE EXPRESSION IN COLORECTAL-CANCER - PRELIMINARY FINDINGS 47
EVALUATION OF TAG-72 (CA-72-4) SERUM MARKER IN PRIMARY DIAGNOSIS IN OVARIAN-CANCER - A COMPARISON WITH CA-125 47
Contribution of platelet-derived CD40 ligand to inflammation, thrombosis and neoangiogenesis 47
TUMOR-ASSOCIATED GLYCOPROTEIN-72 SERUM LEVELS COMPLEMENT CARCINOEMBRYONIC ANTIGEN LEVELS IN MONITORING PATIENTS WITH GASTROINTESTINAL CARCINOMA - A LONGITUDINAL-STUDY 47
TAG-72 expression and its role in the biological evaluation of human colorectal cancer 47
Is CEA serum measurement useful in monitoring breast cancer patients? 46
The insulin-glucose axis in breast cancer - relationship to clinical outcome 46
BRCA1 and BRCA2 mutational analysis in inherited breast/ovarian cancer patients from central Italy 46
Evaluation of the clinical impact of serum tumor markers in gastric cancer. A prospective longitudinal study 46
A Comprehensive Procedural Approach to Genotyping KRAS and BRAF from Paraffin Embedded Tissues for Diagnostic Purposes 46
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio 46
DOPAMINE BETA HYDROXYLASE (DBH) 19BP INSERTION/DEL POLYMORPHISM INFLUENCES MEDICATION OVERUSE HEADACHE 46
Impact of deleterious variants in other genes beyond BRCA1/2 detected in breast/ovarian and pancreatic cancer patients by NGS-based multi-gene panel testing: looking over the hedge 46
Random optimization interactive system based on Kernel learning (RISK) for venous thromboembolism risk assessment in chemotherapy-treated cancer patients 45
In vivo platelet activation is responsible for enhanced vascular endothelial growth factor levels in hypertensive patients 45
TNFA Gene Promoter Polymorphisms and Susceptibility to Recurrent Pregnancy Loss in Italian Women 45
Circulating Levels of Pro-Inflammatory Cytokines in Isolated Limb Perfusion 45
Vascular endothelial growth factor levels in melanoma Relationship with coagulation and platelet activation markers 45
PLATELET PROAGGREGATING ACTIVITY OF HUMAN COLORECTAL TUMOR-CELL LINES DOES NOT CORRELATE WITH THE DEGREE OF DIFFERENTIATION 45
Fibrinolysis components in colorectal carcinoma 45
CA 19-9 monosialoganglioside content of human colorectal tumor cells correlates with tumor cell-induced platelet aggregation 45
Enhanced expression of LINE-1 encoded ORF2 protein in early stages of colon and prostate transformation 45
Association between migraine and sod1 and sod2 genes polymorphisms: the biobim study 45
Machine learning approach to predict medication overuse in migraine patients 45
Validation of a machine learning approach for venous thromboembolism risk prediction in oncology 45
Serum tumor markers in gastrointestinal cancer patients: A prospective longitudinal study 44
Evaluation of the Clinical Impact of Serum Tumor Markers in Colorectal Cancer A Prospective Longitudinal Study 44
Biological response modifiers as adjuvants in monoclonal antibody-based treatment (review) 44
Association between increased tumor necrosis factor alpha levels and acquired activated protein C resistance in patients with metastatic colorectal cancer 44
Clinical value of radiolabeled monoclonal antibodies in the management of carcinoma patients 44
Plasma VEGF levels correlate with haemostatic activation in HCC patients 44
IS THE CD54 PROTEIN (ICAM-1) INVOLVED IN PLATELET-TUMOR CELL-INTERACTION 44
PRKCSH GAG trinucleotide repeat is a mutational target in gastric carcinomas with high-level microsatellite instability 44
A Simple and Effective Method to Analyze Membrane Proteins by SDS-PAGE and MALDI Mass Spectrometry 44
VEGF gene polymorphisms may be associated with an increased risk of fluorouracil-induced diarrhea 44
Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancer 44
Evaluation of TAG-72 and CEA tumor markers in sera of patients with gastrointestinal adenocarcinomas 44
Platelet activation and low-grade inflammation in hypertensives with or without microalbuminuria 44
Influence of interferon on the functional expression of natural killer target structures of murine lymphoma cells 44
Aging: an important risk factor in chemotherapy-associated vascular diseases 44
Biomarkers of platelet activation in acute coronary syndromes 43
Status of the p53, p16, RB1, and HER-2 genes and chromosomes 3, 7, 9, and 17 in advanced bladder cancer: correlation with adjacent mucosa and pathological parameters 43
CA-72-4 MEASUREMENT OF TUMOR-ASSOCIATED GLYCOPROTEIN-72 (TAG-72) AS A SERUM MARKER IN THE MANAGEMENT OF GASTRIC-CARCINOMA 43
Induction of protective host immunity to carcinoembryonic antigen (CEA), a self-antigen in CEA transgenic mice, by immunizing with a recombinant vaccinia-CEA virus 43
Laparoscopic resection of sporadic synchronous gastric and jejunal gastrointestinal stromal tumors: Report of a case 43
An AT-Rich Region in the APC Gene May Cause Misinterpretation of Familial Adenomatous Polyposis Molecular Screening 43
CA 72-4 radioimmunoassay in the diagnosis of malignant effusions. Comparison of various tumor markers 43
An importance of identification of double variant methylenetetrahydrofolate reductase gene C677T and A1298C in cis configuration for pharmacogenetic studies 42
A global assay sensitive to activated protein C abnormalities is predictive for chemotherapy-associated venous thromboembolism 42
VEGF and VTE Risk in Cancer Patients-Letter 42
Serum Concentration of Soluble Adhesion Molecules and Cytokines in Patients with Colorectal Cancer 42
Early diagnosis of hepatocellular carcinoma in cirrhotic patients: Evaluation of new biologic markers 42
Carcinoembryonic antigen as a target for specific antitumor immunotherapy of head and neck cancer 42
Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab 42
Case-control genetic association studies in migraine: a 7-year experience at the Interinstitutional Multidisciplinary Biobank (BioBIM) of IRCCS San Raffaele Pisana 42
A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cells 42
Totale 4.972
Categoria #
all - tutte 138.597
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 138.597


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.264 135 181 41 3 105 148 95 55 99 59 2.113 230
2021/20223.140 19 961 966 5 4 6 348 352 47 389 5 38
2022/20231.172 703 24 17 70 49 13 7 53 41 81 110 4
2023/2024710 6 2 21 152 36 48 15 35 0 63 5 327
2024/20252.898 158 642 144 110 162 499 197 145 325 20 80 416
2025/202655 55 0 0 0 0 0 0 0 0 0 0 0
Totale 12.424